Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Goldsmith

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
European Journal of Heart Failure|October 8, 2015
Contrasting acute and chronic effects of tolvaptan on serum osmolality in the EVEREST trialMuthiah Vaduganathan, Steven R Goldsmith, Michele Senni, et al.
Journal of Cardiac Failure|November 30, 2011
Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failureSteven R Goldsmith, David T Gilbertson, Shari A Mackedanz, et al.
Journal of Cardiac Failure|October 18, 2008
Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot studySteven R Goldsmith, Uri Elkayam, W Herbert Haught, et al.
Journal of Critical Care|March 12, 2017
The effect of targeted temperature management on QT and corrected QT intervals in patients with cardiac arrestZachary Rosol, David F Miranda, Yader Sandoval, et al.
American Heart Journal|July 31, 2018
Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exerciseLouise Balling, Jakob Hartvig Thomsen, Emil Wolsk, et al.
European Journal of Heart Failure|March 2, 2018
Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HFJustin L Grodin, Spencer Carter, Bradley A Bart, et al.
The American Journal of Medicine|October 1, 2013
Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendationsJoseph G Verbalis, Steven R Goldsmith, Arthur Greenberg, et al.
The American Journal of Medicine|June 28, 2014
The replyJoseph G Verbalis, Steven R Goldsmith, Arthur Greenberg, et al.
Journal of Cardiac Failure|November 14, 2020
Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI TrialSteven R Goldsmith, Daniel Burkhoff, Finn Gustafsson, et al.
Heart Failure Reviews|May 11, 2012
Prognostic implications of renal dysfunction in patients hospitalized with heart failure: data from the last decade of clinical investigationsFilippo Brandimarte, Muthiah Vaduganathan, Gian Francesco Mureddu, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
European Journal of Heart Failure|October 8, 2015
Contrasting acute and chronic effects of tolvaptan on serum osmolality in the EVEREST trialMuthiah Vaduganathan, Steven R Goldsmith, Michele Senni, et al.
Journal of Cardiac Failure|November 30, 2011
Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failureSteven R Goldsmith, David T Gilbertson, Shari A Mackedanz, et al.
Journal of Cardiac Failure|October 18, 2008
Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot studySteven R Goldsmith, Uri Elkayam, W Herbert Haught, et al.
Journal of Critical Care|March 12, 2017
The effect of targeted temperature management on QT and corrected QT intervals in patients with cardiac arrestZachary Rosol, David F Miranda, Yader Sandoval, et al.
American Heart Journal|July 31, 2018
Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exerciseLouise Balling, Jakob Hartvig Thomsen, Emil Wolsk, et al.
European Journal of Heart Failure|March 2, 2018
Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HFJustin L Grodin, Spencer Carter, Bradley A Bart, et al.
The American Journal of Medicine|October 1, 2013
Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendationsJoseph G Verbalis, Steven R Goldsmith, Arthur Greenberg, et al.
The American Journal of Medicine|June 28, 2014
The replyJoseph G Verbalis, Steven R Goldsmith, Arthur Greenberg, et al.
Journal of Cardiac Failure|November 14, 2020
Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI TrialSteven R Goldsmith, Daniel Burkhoff, Finn Gustafsson, et al.
Heart Failure Reviews|May 11, 2012
Prognostic implications of renal dysfunction in patients hospitalized with heart failure: data from the last decade of clinical investigationsFilippo Brandimarte, Muthiah Vaduganathan, Gian Francesco Mureddu, et al.
Pageof 6